AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease
NCT: NCT07721454 · COMPLETED
Brief Summary
The research project studies the possibility of using an artificial intelligence-based system in patients with advanced chronic liver disease (liver cirrhosis) to record variations in a patient's health status, with the aim of early identification of clinical improvement or deterioration. The system is based on the collection and processing of various clinical parameters through an Apple Watch. The study aims to evaluate whether the data generated by this system correlate with patients' clinical evolution and whether its use may ultimately contribute to improved care management and quality of life.
Frequently Asked Questions
What is AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease?
AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease is a clinical trial registered under NCT07721454. Current status: COMPLETED.
What is the status of NCT07721454?
The current status of NCT07721454 (AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease) is: COMPLETED.
When did AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease start?
AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease started on 2022-12-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.